T CELLS MODIFIED TO OVEREXPRESS PHF19

Technology
E-107-2017
Patent ID
E-107-2017-0-EP-03
Country
EP
Application Type
National Stage
Patent Status
Issued
Patent Number
 
Publication Number
3635098
Application Number
18737062.2
IC
NCI
Date Filed
Date Issued
Patent PDF
 
Related Technologies
TAB-4030     Overexpression of Phf19 on T Cells Enhances Therapeutic Effects of T Cell-Based Therapies (such as Chimeric Antigen Receptor [CAR] Therapies)